Symptom-Triggered vs. Fixed-Schedule Benzodiazepines for Alcohol Withdrawal

Abstract This chapter compares symptom-triggered and fixed-schedule benzodiazepine administration for alcohol withdrawal treatment. The underlying study took place in Switzerland with 117 patients and showed that symptom-triggered dosing reduces both the total amount of benzodiazepines used and the treatment duration compared to the fixed-schedule approach. The symptom-triggered group required significantly less oxazepam (37.5 mg) and had a shorter treatment duration (20 hours) than the fixed-schedule group (231.4 mg and 62.7 hours, respectively). Although the symptom-triggered group reported higher withdrawal severity scores, they experience no increase in complications or discomfort. Finally, the study that symptom-triggered benzodiazepines offer a safer, more efficient method for managing alcohol withdrawal, reducing treatment time and medication use without compromising patient safety or comfort.